SRPT icon

Sarepta Therapeutics
SRPT

Overview Fund Activity

114 hedge funds and large institutions have $639M invested in Sarepta Therapeutics in 2014 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 32 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+6
Holders Change %
+5.56%
% of All Funds
3.29%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
22
Increased
47
Reduced
32
Closed
16
Calls
$83M
Puts
$82.1M
Net Calls
+$887K
Net Calls Change
+$27.9M

Top Buyers

1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
$78.9M
2
PC
PointState Capital
New York
$14.4M
3
AGA
Altrinsic Global Advisors
Connecticut
$4.57M
4
EAM
Eventide Asset Management
Massachusetts
$6.23M
5
HCMT
Highland Capital Management (Texas)
Texas
$4.36M

Top Sellers

1
VAM
Visium Asset Management
New York
$0
2
PA
Perceptive Advisors
New York
$69.2M
3
BC
Broadfin Capital
New York
$3.64M
4
Capital Fund Management (CFM)
Capital Fund Management (CFM)
France
$0
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
$4.37M
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
126
Jane Street
New York
– -$227K -11,153 Closed
FNYS
127
First New York Securities
New York
– -$152K -7,500 Closed
BNP Paribas Financial Markets
128
BNP Paribas Financial Markets
France
– -$8.86K -435 Closed
LTFS
129
Ladenburg Thalmann Financial Services
Florida
– -$6K -300 Closed
TRCT
130
Tower Research Capital (TRC)
New York
– -$2K -118 Closed
2 3 4 5
6